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Abstract
Context Pseudoacromegaly describes conditions with an
acromegaly related physical appearance without abnormal-
ities in the growth hormone (GH) axis. Acromegaloid
facies, together with hypertrichosis, are typical manifesta-
tions of Cantú syndrome.
Case description We present a three-generation family with
5 affected members, with marked acromegaloid facies and
prominent hypertrichosis, due to a novel missense variant in
the ABCC9 gene. The proband, a 2-year-old girl, was
referred due to marked hypertrichosis, noticed soon after
birth, associated with coarsening of her facial appearance.
Her endocrine assessment, including of the GH axis, was
normal. The proband's father, paternal aunt, and half-sibling
were referred to the Endocrine department for exclusion of
acromegaly. Although the GH axis was normal in all, two
subjects had clinically non-functioning pituitary macro-
adenomas, a feature which has not previously been asso-
ciated with Cantú syndrome.
Conclusions Activating mutations in the ABCC9 and, less
commonly, KCNJ8 genes—representing the two subunits of
the ATP-sensitive potassium channel—have been linked
with Cantú syndrome. Interestingly, minoxidil, a well-
known ATP-sensitive potassium channel agonist, can cause
a similar phenotype. There is no clear explanation why
activating this channel would lead to acromegaloid features
or hypertrichosis. This report raises awareness for this
complex condition, especially for adult or pediatric endo-
crinologists who might see these patients referred for eva-
luation of acromegaloid features or hirsutism. The link
between Cantú syndrome and pituitary adenomas is cur-
rently unclear.
Keywords Cantú syndrome ● ABCC9 ● pseudoacromegaly ●
familiar pituitary adenoma
Introduction
The term pseudoacromegaly is used to describe cases where
an acromegaly related physical appearance can be observed
without any abnormality in the growth hormone (GH) axis.
Coarse facial appearance with hypertrichosis are typical
manifestations of Cantú syndrome [1–3].
Cantú syndrome, also known as hypertrichotic osteo-
chondrodysplasia, is a heterogeneous condition that usually
includes acromegaloid facial features, hypertrichosis, as
well as skeletal and cardiac abnormalities (Table 1) [1, 4, 5].
Earlier reports have used different terms such as acrome-
galoid facial appearance (AFA) syndrome [6] or hyper-
trichosis acromegaloid facial features (HAFF) syndrome
following the report of a family with 4 members affected
with an AFA and congenital generalized hypertrichosis [2].
These conditions are phenotypically overlapping with
Cantú syndrome and in fact represent a spectrum of the
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Table 1 Major clinical features of Cantú syndrome
Cantú syndrome clinical manifestations III.3 II.8 II.3 III.1 Molecularly proven Cantú
syndrome n= 30 [1, 4, 5, 15, 16]
Cranio-facial dysmorphology
Coarse facial appearance + + + + 30/30 [1, 4, 5, 15, 16]
Broad nasal bridge + + + + 24/26 [1, 5, 15]
Bulbous nose + + + + 29/30 [1, 4, 5, 15, 16]
Small nose/anteverted nostrils − − − 11/13 [5, 15]
Prominent mouth with thick lips + + + − 29/30 [1, 4, 5, 15, 16]
Long philtrum + + + + 28/29 [1, 4, 5, 15]
Macroglossia + + + + 15/28 [1, 5, 15, 16]
Gingival hyperplasia − − − + 10/18 [1, 4, 5, 16]
High or narrow palate − − − − 9/12 [5, 16]
Anterior open bite − − − − 3/11 [5]
Epicanthal folds − − − − 19/27 [1, 5, 15]
Short neck − − − − 5/11 [5]
Multiple labial frenula − − − − One single case [16]
Hair
Congenital generalized hypertrichosis + + + + 30/30 [1, 4, 5, 15, 16]
Abundant/curly eyelashes − − − − 9/11 [5]
Spiky hair − − − − 2/14 [1]
Cardiovascular
Cardiomegaly − − + − 15/30 [1, 5, 15, 16]
Concentric hypertrophy of the ventricles − − − − 13/30 [1, 4, 5, 15, 16]
Pericardial effusion − + − − 4/29 [1, 4, 5, 15]
Pulmonary hypertension n.a. n.a. n.a. n.a. 4/29 [1, 4, 5, 15]
Patent ductus arteriosus n.a. n.a. n.a. n.a. 11/16 [1, 4]
Patent foramen ovale n.a. n.a. n.a. n.a. 2/16 [1, 15]
Atrial septal defects − − − − 2/14 [1]
AV block or fascicular block − − − − 1/2 [15]
Thoracic aorta aneurism n.a. n.a. n.a. n.a. One single case [15]
Myocarditis − − − +
Skeletal abnormalities
Thickened calvarium − − + − 9/30 [1, 4, 5, 15, 16]
Craniosynostosis − − − − 1/2 [15]
Broad ribs − − − − 16/30 [1, 4, 5, 15, 16]
Narrow thorax − − − − 4/11 [5]
Platyspondyly and ovoid vertebral bodies n.a. n.a. n.a. n.a. 5/26 [1, 5, 16]
Narrow obturator foramen n.a. n.a. n.a. n.a. 2/11 [5]
Coxa vara/valga − − − − 3/11 [5]
Scoliosis − − − − 6/27 [1, 4, 5]
Osteopenia n.a. n.a. n.a. n.a. 2/12 [5, 16]
Delayed bone age − n.a. n.a. n.a. 3/12 [5, 16]
Hypoplastic bones − − − − 2/26 [1, 5, 16]
Erlenmeyer ﬂask-like long bones with metaphyseal ﬂaring n.a. n.a. n.a. n.a. 6/26 [1, 5, 16]
Hyperextensibility of joints − − − − 15/27 [1, 4, 5]
Enlarged medullary canal n.a. n.a. n.a. n.a. 8/12 [5, 16]
Pectus carinatum − − − − 2/11 [5]
Endocrine
same condition. Following the description of activating
ABCC9 mutations in Cantú syndrome [1, 5], we have
analyzed a family published 20 years ago by Irvine [2] and
identiﬁed a novel missense ABCC9 variant carried by the
affected members.
We aim to raise awareness of this complex condition,
with prominent features resembling endocrine conditions
and having signiﬁcant cardiological complications. More-
over, we highlight a potential link between familial pituitary
adenomas and Cantú syndrome.
Table 1 continued
Cantú syndrome clinical manifestations III.3 II.8 II.3 III.1 Molecularly proven Cantú
syndrome n= 30 [1, 4, 5, 15, 16]
Skin
Loose, soft and/or wrinkled skin − − − − 18/27 [1, 5, 15]
Deep palmar and plantar creases − − − − 14/27 [1, 5, 15]
Persistent ﬁngertip pads − − − − 12/26 [1, 5, 16]
Keloid formation − − − − One single case [16]
Endocrine system
Enlarged pituitary sella turcica − − − − One single case [5]
Pituitary hyperplasia − − − − One case with CS phenotype, not
proven molecularly [11]
GH deﬁciency − − − − One single case associated to
KCNJ8 gene mutation [8]
Pituitary adenoma + − + − No reported cases
Other manifestations
Macrosomia at birth (adult height usually normal) − − − − 19/29 [1, 4, 5, 15]
Polyhydramnios n.a. n.a. n.a. n.a. 12/29 [1, 4, 5, 15]
Developmental and/or speech delay − − − − 10/29 [1, 4, 5, 15]
Edema/ lymphedema − − − − 5/11 [5]
Pyloric stenosis − − − − 1/11 [5]
Feeding problems and poor intestinal motility − − − − 8/14 [1]
Hepatomegaly/ splenomegaly − − − − 2/14 [1]
Immune dysfunction and recurrent infections − − − − 11/27 [1, 5, 15]
Tracheo/broncho/laryngomalacia n.a. n.a. n.a. n.a. 3/14 [1]
Hoarse voice − − − − 3/14 [1]
Large hands − − + − 2/3 [15, 16]
Umbilical hernia − − − − 5/12 [5, 15]
Renal abnormalities − − − − 1/11 [5]
Genital abnormalities − − + (small uterus) − 3/12 [5, 16]
Neurological manifestations
Migraines − − − − 5/10 [12]
Seizures − − − − 2/10 [12]
Hypotonia − − − − 3/10 [12]
Autism − − − − 1/10 [12]
Attention difﬁculties and behavioral problems − − − − 4/10 [12]
Cerebral atrophy − − − − 2/10 [12]
White matter changes + − − − 3/10 [12]
Tortuous cerebral vasculature − − − − 5/10 [12]
Tortuous retinal vessels n.a. n.a. n.a. n.a. 2/10 [12]
Features present in the reported alive family members are marked with (+); absent features are marked with (−); features that are unknown or were
not actively investigated are marked with (n.a.). The right column shows the presence of manifestations in patients with mutation positive Cantú
syndrome reported in the literature
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Case description
The proband (III.3) was referred at age of 2 years to the
Dermatology department due to prominent generalized
hypertrichosis, noticed soon after birth, and coarsening
facial appearance, with broadening of her nose and lower lip
thickening (Fig. 1a–d). Her height and weight were just
below the 97th centile, with her bone age matching the
chronological age. Baseline pituitary function assessment
was normal, including the GH axis. Over the following 20
years, her acromegaloid features and hypertrichosis pro-
gressed (Fig. 1b, d). The patient manages her hypertrichosis
cosmetically and with clothing. Her ﬁnal adult height is 171
cm (above the 90th centile). At the age of 14 years she was
diagnosed with a 12 mm non-functioning pituitary adenoma
(Fig. 2), which has been stable in size over the last 8 years.
The proband's father (II.8) was referred to the Endocri-
nology department due to a clinical suspicion of acrome-
galy, particularly because of acromegaloid facies (Fig. 1e).
His GH axis and pituitary MRI scan were normal. Over the
last 20 years, his acromegaloid features have been stable
(Fig. 1f, g). At the age of 24 years he presented with non-
speciﬁc chest pain and shortness of breath and was found to
have a pericardial effusion for which no cause was identi-
ﬁed. He later had repeated pericardiocentesis for recurrent
effusions and subsequently had pericardial fenestration at
the age of 30 years.
The proband's paternal aunt (II.3) was ﬁrst seen at the
Endocrinology department for exclusion of acromegaly. In
addition to her acromegaloid facial appearance (Fig. 1h),
she had terminal hypertrichosis. Her GH axis assessment
was normal, with a normal serum IGF-1. Twenty years
later, progression of coarse facial features is noticeable (Fig.
1i–j), while the hypertrichosis has remained stable requiring
no speciﬁc treatment. At age of 44 years she was diagnosed
with a 13 mm non-functioning pituitary adenoma (Fig. 2),
unchanged in size over the last 14 years. She was noted to
have mild hyperprolactinemia, likely due to a stalk effect
(1030 mU/l [NR< 500]), and secondary adrenal insufﬁ-
ciency was also documented (suboptimal cortisol peak of
461 nmol/l on an insulin tolerance test, and 300 nmol/l on a
short Synacthen test) for which she was commenced on
hydrocortisone replacement therapy. Moderate thickening
of the posterior calvarium was identiﬁed on a skull X-ray,
and also noted on the MRI images (Fig. 2c). She was noted
to have cardiomegaly, although she does not have hyper-
tension or valve abnormalities. She has been recently
diagnosed with a grade III inﬁltrating ductal breast carci-
noma; one of her 53-year-old sisters had the same condition.
BRCA1 and BRCA2 genetic testing did not reveal any
abnormality.
The proband's half-sister (III.1) was referred to the
Endocrinology department due to coarse facial features, a
prominent forehead, thickened lips, long philtrum, and
enlarged nose, and hypertrichosis. Her endocrine assess-
ment was normal, including a normal serum IGF-1 and
normal pituitary CT scan. At the age of 25 years she had an
episode of chest pain associated with a mild troponin ele-
vation, with a 15% rise on a second sample, attributed to a
myocarditis.
The proband's grandfather (I.2), described as “hairy”, was
never assessed by the genetic or medical departments.
The pedigree is consistent with an autosomal dominant
inheritance pattern (Fig. 3) [2].
Genetic testing
The ABCC9 gene has been linked with Cantú syndrome in
2012 [1, 5], and some of the patients previously described
as suffering from AFA and HAFF syndromes, were also
identiﬁed with mutations in ABCC9 [4]. ABCC9 encodes a
member of the superfamily of adenosine triphosphate
(ATP)-binding cassette transporter subfamily C, commonly
referred to as SUR2 (sulfonylurea receptor 2) protein. This
transmembrane protein functions as a subunit of ATP-
sensitive potassium channels in cardiac, skeletal, vascular,
and non-vascular smooth muscle, and other tissues. Co-
expression of SUR2 with the pore-forming inward rectiﬁer
proteins, Kir6.1 (encoded by KCNJ8) or Kir6.2 (KCNJ11)
generates functional ATP-sensitive potassium channels [3].
All pathogenic variants in ABCC9 reported to date in Cantú
syndrome are gain-of-function missense mutations [1, 3, 5].
Activation of ABCC9 reduces ATP-mediated potassium
channel inhibition, thereby opening the channel [1, 5]. More
rarely, Cantú syndrome can be caused by mutations in the
KCNJ8 gene [7].
We sequenced the ABCC9 gene and identiﬁed a novel
missense variant in the affected subjects: c.4039 C> T (p.
Arg1347Cys) (Fig. 3). This missense variant, not reported
in the literature and not present in the GnomAD database,
causes a substitution of a highly conserved arginine residue
for a cysteine at codon 1347 in the second nucleotide
binding domain of ABCC9. In silico bioinformatics analysis
(SIFT and PolyPhen) supports the pathogenicity of this
variant.
Discussion
The prevalence of Cantú syndrome is unknown. Males and
females are equally affected and there is no established
phenotype–genotype correlation. This conditions is
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inherited in an autosomal dominant manner, and penetrance
thus far appears to be complete [3, 8].
It is currently unclear as to how activating ABCC9
mutations lead to hypertrichosis, acromegaloid facial fea-
tures, osteochondrodysplasia, and cardiovascular anomalies,
while these features remarkably overlap with the side-
effects of minoxidil, which binds to SUR2 resulting in
ATP-sensitive potassium channel opening and activation
[3]. Minoxidil promotes keratinocyte proliferation, glyco-
saminoglycan, and elastin production from skin ﬁbroblasts,
Fig. 1 Facial appearance and generalized terminal hypertrichosis of the proband at the ages of 2 (a, c) and 22 years (b, d). The proband's father at
the ages of 28 (e) and 48 years (f, g), and the proband's paternal aunt at the ages of 36 (h) and 57 years (i, j)
Endocrine
thereby changing connective tissue composition [9].
Regarding hypertrichosis, potassium channel opening, with
consequent vasodilatation, may increase the blood supply,
oxygen, and nutrients to the hair follicles leading to hair
growth. Cardiovascular effects have been attributed to
reduced vascular tone, which may explain pericardial
effusions seen in Cantú syndrome patients [3, 10] and
minoxidil-treated patients [10]. ATP-sensitive potassium
channels are expressed in chondrocytes and osteoblasts, but
their role in bone maturation as the explanation for skeletal
abnormalities in ABCC9-related disorders is unknown [3].
No major endocrinopathies have been reported in Cantú
syndrome [11]. The GH axis, often investigated due to
possible acromegaly (the main differential diagnostic
entity), has been shown to be normal [1, 3–5]. There is,
however, one single case of a boy with Cantú syndrome due
to a KCNJ8 gene mutation found with GH deﬁciency [7].
No pituitary adenomas have been reported in Cantú syn-
drome, despite the fact that these patients commonly
undergo brain imaging as part of investigations for neuro-
logical symptoms or as a routine procedure to exclude
cerebrovascular abnormalities (Table 1) [4]. No pituitary
adenomas were reported in a series of ten patients with
genetically conﬁrmed Cantú syndrome who had neuroi-
maging studies [12]. Scurr et al. reported one patient with a
mild pituitary fossa enlargement and a moderate
enlargement of the pituitary gland (10× 11 mm) extending
into the suprasellar cistern, but no pituitary adenoma was
visible in this case [11]. In our kindred, we have two cases
with non-functioning pituitary adenoma. Although pituitary
adenomas are not rare in the general population, most are
small incidentally found lesions [13]. Here we report
pituitary macroadenomas in two family members, one
found at the age of 14 years. These may represent a Cantú
syndrome-related feature or the independent disease of
familial isolated pituitary adenoma [14].
The differential diagnosis for Cantú syndrome includes
acromegaly, hypothyroidism, hirsutism-related endocrino-
pathies such polycystic ovary syndrome, minoxidil use, or
other rare pseudoacromegaly conditions such pachyderma-
toperiostosis, Berardinelli-Seip, Sotos, or Weaver syn-
dromes; therefore, these patients are likely to be referred to
adult or pediatric endocrine clinics [3, 4].
In summary, we present a ﬁve-member three-generation
family with Cantú syndrome due to a novel missense var-
iant in ABCC9 gene showing full penetrance, and two
family members with non-functioning pituitary adenomas.
We show their acromegaloid facial phenotype over a 20-
year-period combined with marked generalized hyper-
trichosis, and draw attention to their cardiac complications.
This family also shows familial pituitary adenoma and, as
this was not described in other patients with Cantú
Fig. 2 Pituitary imaging inves-
tigations in the proband (a, b)
and the proband's paternal aunt
(c, d). Mildly thickened calvar-
ium can be seen (c)
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syndrome, it is unclear whether this feature is part of Cantú
syndrome or a coincidental ﬁnding. Familial pituitary ade-
nomas have a heterogeneous genetic background [14], and
further studies are needed to see if there is indeed a link
with ABCC9.
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